Use your antibodies-online credentials, if available.
Glycosyltransferase which participates in glycosylation of alpha-dystroglycan.
Showing 2 out of 3 products:
Reduced levels of GYLTL1B and ISPD (显示 ISPD 抗体) mRNA associated with increased patient mortality and are the likely cause of alphaDG hypoglycosylation in ccRCC.
LARGE2 is negatively regulated by Snail (显示 SNAI1 抗体) and/or ZEB1 (显示 ZEB1 抗体), revealing a mechanistic basis for alphaDG hypoglycosylation during prostate cancer progression and metastasis.
Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer
LARGE2 was found to support the maturation of alpha-dystroglycan more effectively than LARGE.
The LARGE2 may play a differential role in stabilizing the basement membrane and modifying its functions by augmenting the interactions between laminin globular domain-containing ECM proteins and proteoglycans (PGs).
Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of alpha-dystroglycan in cells and tissues.
Glycosyltransferase which participates in glycosylation of alpha-dystroglycan. May carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. Has a higher activity toward alpha-dystroglycan than LARGE.
glycosyltransferase-like protein LARGE2-A
, glycosyltransferase-like 1B-A
, glycosyltransferase-like 1B
, glycosyltransferase-like protein LARGE2
, glycosyltransferase-like protein LARGE2-like
, like-glycosyltransferase 2
, ortholog of mouse glycosyltransferase-like 1B
, glycoslytransferase-like 1B
, acetylglucosaminyltransferase-like 1A
, acetylglucosaminyltransferase-like protein
, glycosyltransferase-like 1A
, glycosyltransferase-like protein LARGE1